Atopic Dermatitis, Burden, Caregiver, Eczema, Eczema Atopic Dermatitis
Conditions
Keywords
atopic dermatitis, quality of life, real-world
Brief summary
This study will address this gap by providing comprehensive data on disease burden from a caregiver perspective in a Canadian population, ultimately supporting improved clinical decision-making and healthcare resource allocation.
Interventions
OTHERNo Intervention: Observational Cohort
No specific intervention is assess in this study. Observational cohort.
Sponsors
PeriPharm
Study design
Observational model
COHORT
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
1. Aged ≥18 years; 2. Caregiver of a child aged ≥2 to ≤11 years with mild to moderate atopic dermatitis; 3. Able to read and understand French or English; 4. Willing and able to provide written informed consent.
Exclusion criteria
1. Caregivers whose child has been diagnosed with severe atopic dermatitis ; 2. Caregivers whose child is currently treated with oral or topical Janus Kinase Inhibitor); 3. Caregivers whose child is currently participating in a clinical trial for atopic dermatitis; 4. Other parent or caregiver within the household of the child with atopic dermatitis.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| To estimate work productivity loss in caregivers of children with mild or moderate atopic dermatitis. | At recruitment | Using the Work Productivity and Activity Impairment questionnaire. This questionnaire provides a quantitative measure of impairment over the last 7 days and includes four metrics: absenteeism (work time missed because of health issues during the past 7 days), presenteeism (impairment while working due to health issues during the past 7 days), overall work productivity loss (combination of absenteeism and presenteeism), and activity impairment. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| To estimate family burden of mild to moderate atopic dermatitis in children, as reported by caregivers | At recruitment | The Dermatitis Family Impact (DFI) questionnaire will be administered to caregivers to evaluate the family burden of pediatric atopic dermatitis. The DFI is a validated, 10-item instrument specifically developed for atopic dermatitis, covering domains such as housework, feeding, sleep, leisure activities, time spent shopping, expenditure, physical fatigue, emotional distress, relationships, helping with treatment, with a 7-day recall period. Each item is scored on a 4-point Likert scale ("Not at all = 0" to "Very much = 3"), with higher total scores indicating greater impact |
Contacts
CONTACTJean Lachaine, Ph. D.
Outcome results
None listed